<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>13</Volume>
				<Issue>5</Issue>
				<PubDate PubStatus="epublish">
					<Year>2012</Year>
					<Month>05</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Methylenetetrahydrofolate Reductase C677T Polymorphism and Cervical Cancer Risk: a Meta-Analysis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2193</FirstPage>
			<LastPage>2197</LastPage>
			<ELocationID EIdType="pii">26454</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in the metabolism of folate,and the role of MTHFR C677T polymorphism in cervical carcinogenesis is still controversial. &lt;br/&gt;&lt;b&gt;Method&lt;/b&gt;: Weperformed a meta-analysis of all relevant case-control studies that examined any association between the C677Tpolymorphism and cervical cancer risk. We estimated summary odds ratios (ORs) with their confidence intervals(CIs) to assess links. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Finally, 10 studies with a total of 2113 cervical cancer cases and 2804 controls wereincluded. Results from this meta-analysis showed that significantly elevated cervical cancer risk was associatedwith the MTHFR T allele in the Asian population under conditions of two genetic comparison models (for TTvs. CC, OR = 1.37, 95%CI 1.00-1.87, P = 0.050; for TT vs. TC+CC: OR = 1.34, 95%CI 1.01-1.77, P = 0.039).However, there was no obvious association between the MTHFR C677T polymorphism and cervical cancer riskin the other populations. &lt;br/&gt;&lt;b&gt;Conclusion&lt;/b&gt;: The MTHFR C677T polymorphism is associated with cervical cancer riskin Asians, while any possible link in the Caucasian population needs further studies.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">methylenetetrahydrofolate reductase</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Genetic polymorphism</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">cervical cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meta-analysis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_26454_6b04e4b9d19e0da8e3f5d7f1791e7e89.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
